Role of tyrosine kinase and PKC in the vasoconstrictor response to 20- HETE in renal arterioles

Cheng Wen Sun, J R Falck, David R. Harder, Richard J. Roman

Research output: Contribution to journalArticle

99 Citations (Scopus)

Abstract

The present study examined the hypothesis that activation of protein kinase C (PKC), components of the mitogen-activated protein (MAP) kinase pathway, or both contributes to the inhibitory effects of 20- hydroxyeicosatetraenoic acid (20-HETE) on K+-channel activity and its vasoconstrictor response in renal arterioles. 20-HETE (0.1 to 50 μmol/L) dose-dependently produced a 30% increase in PKC activity and a fivefold rise in the expression of active extracellular signal-regulated kinase 1 (ERK1) and ERK2 proteins in renal microvessels. 20-HETE (0.01 to 1 μmol/L) reduced the diameter of isolated perfused renal interlobular arterioles by 33±2%. Blockade of PKC activity with an N-myristoylated PKC pseudosubstrate inhibitor (Myr-PKCi, 100 μmol/L) or calphostin C (0.5 μmol/L) had no significant effect on the vasoconstrictor response to 20-HETE. In contrast, the tyrosine kinase inhibitors genistein (30 μmol/L) and tyrphostin 25 (10 μmol/L) reduced the response to 20-HETE by 76.5±2.1% and 67.5±1.8%, respectively. A specific inhibitor of mitogen-activated extracellular signal- regulated kinase (MEK), PD98059, had no effect on the vasoconstrictor response to 20-HETE. In cell-attached patches on renal vascular smooth muscle cells, 20-HETE reduced the open state probability of a large-conductance K+ channel (from 0.0026±0.0004 to 0.0006±0.0001). The Myr-PKCi (100 μmol/L) did not alter the inhibitory effects of 20-HETE on this channel. In contrast, the tyrosine kinase inhibitor genistein (30 μmol/L) blocked the inhibitory effects of 20-HETE on the large-conductance K+ channel. These data suggest that 20-HETE activates the MAP kinase system in renal arterioles and that the activation of a tyrosine kinase, which is proximal to MEK in this cascade, contributes to the inhibitory effects of 20-HETE on K+-channel activity and its vasoconstrictor effects in the renal arterioles.

Original languageEnglish (US)
Pages (from-to)414-418
Number of pages5
JournalHypertension
Volume33
Issue number1 II
StatePublished - Jan 1999

Fingerprint

Arterioles
Vasoconstrictor Agents
Protein-Tyrosine Kinases
Protein Kinase C
Kidney
Genistein
Mitogen-Activated Protein Kinase Kinases
Mitogen-Activated Protein Kinases
20-hydroxy-5,8,11,14-eicosatetraenoic acid
Mitogen-Activated Protein Kinase 3
Extracellular Signal-Regulated MAP Kinases
Microvessels
Vascular Smooth Muscle
Mitogens
Smooth Muscle Myocytes

Keywords

  • Arachidonic acid
  • Cytochrome P450
  • Kinase
  • Muscle, smooth, vascular
  • Potassium channels
  • Renal circulation

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Role of tyrosine kinase and PKC in the vasoconstrictor response to 20- HETE in renal arterioles. / Sun, Cheng Wen; Falck, J R; Harder, David R.; Roman, Richard J.

In: Hypertension, Vol. 33, No. 1 II, 01.1999, p. 414-418.

Research output: Contribution to journalArticle

Sun, Cheng Wen ; Falck, J R ; Harder, David R. ; Roman, Richard J. / Role of tyrosine kinase and PKC in the vasoconstrictor response to 20- HETE in renal arterioles. In: Hypertension. 1999 ; Vol. 33, No. 1 II. pp. 414-418.
@article{04c28c3e5f3b42a9b2a225118dee969d,
title = "Role of tyrosine kinase and PKC in the vasoconstrictor response to 20- HETE in renal arterioles",
abstract = "The present study examined the hypothesis that activation of protein kinase C (PKC), components of the mitogen-activated protein (MAP) kinase pathway, or both contributes to the inhibitory effects of 20- hydroxyeicosatetraenoic acid (20-HETE) on K+-channel activity and its vasoconstrictor response in renal arterioles. 20-HETE (0.1 to 50 μmol/L) dose-dependently produced a 30{\%} increase in PKC activity and a fivefold rise in the expression of active extracellular signal-regulated kinase 1 (ERK1) and ERK2 proteins in renal microvessels. 20-HETE (0.01 to 1 μmol/L) reduced the diameter of isolated perfused renal interlobular arterioles by 33±2{\%}. Blockade of PKC activity with an N-myristoylated PKC pseudosubstrate inhibitor (Myr-PKCi, 100 μmol/L) or calphostin C (0.5 μmol/L) had no significant effect on the vasoconstrictor response to 20-HETE. In contrast, the tyrosine kinase inhibitors genistein (30 μmol/L) and tyrphostin 25 (10 μmol/L) reduced the response to 20-HETE by 76.5±2.1{\%} and 67.5±1.8{\%}, respectively. A specific inhibitor of mitogen-activated extracellular signal- regulated kinase (MEK), PD98059, had no effect on the vasoconstrictor response to 20-HETE. In cell-attached patches on renal vascular smooth muscle cells, 20-HETE reduced the open state probability of a large-conductance K+ channel (from 0.0026±0.0004 to 0.0006±0.0001). The Myr-PKCi (100 μmol/L) did not alter the inhibitory effects of 20-HETE on this channel. In contrast, the tyrosine kinase inhibitor genistein (30 μmol/L) blocked the inhibitory effects of 20-HETE on the large-conductance K+ channel. These data suggest that 20-HETE activates the MAP kinase system in renal arterioles and that the activation of a tyrosine kinase, which is proximal to MEK in this cascade, contributes to the inhibitory effects of 20-HETE on K+-channel activity and its vasoconstrictor effects in the renal arterioles.",
keywords = "Arachidonic acid, Cytochrome P450, Kinase, Muscle, smooth, vascular, Potassium channels, Renal circulation",
author = "Sun, {Cheng Wen} and Falck, {J R} and Harder, {David R.} and Roman, {Richard J.}",
year = "1999",
month = "1",
language = "English (US)",
volume = "33",
pages = "414--418",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1 II",

}

TY - JOUR

T1 - Role of tyrosine kinase and PKC in the vasoconstrictor response to 20- HETE in renal arterioles

AU - Sun, Cheng Wen

AU - Falck, J R

AU - Harder, David R.

AU - Roman, Richard J.

PY - 1999/1

Y1 - 1999/1

N2 - The present study examined the hypothesis that activation of protein kinase C (PKC), components of the mitogen-activated protein (MAP) kinase pathway, or both contributes to the inhibitory effects of 20- hydroxyeicosatetraenoic acid (20-HETE) on K+-channel activity and its vasoconstrictor response in renal arterioles. 20-HETE (0.1 to 50 μmol/L) dose-dependently produced a 30% increase in PKC activity and a fivefold rise in the expression of active extracellular signal-regulated kinase 1 (ERK1) and ERK2 proteins in renal microvessels. 20-HETE (0.01 to 1 μmol/L) reduced the diameter of isolated perfused renal interlobular arterioles by 33±2%. Blockade of PKC activity with an N-myristoylated PKC pseudosubstrate inhibitor (Myr-PKCi, 100 μmol/L) or calphostin C (0.5 μmol/L) had no significant effect on the vasoconstrictor response to 20-HETE. In contrast, the tyrosine kinase inhibitors genistein (30 μmol/L) and tyrphostin 25 (10 μmol/L) reduced the response to 20-HETE by 76.5±2.1% and 67.5±1.8%, respectively. A specific inhibitor of mitogen-activated extracellular signal- regulated kinase (MEK), PD98059, had no effect on the vasoconstrictor response to 20-HETE. In cell-attached patches on renal vascular smooth muscle cells, 20-HETE reduced the open state probability of a large-conductance K+ channel (from 0.0026±0.0004 to 0.0006±0.0001). The Myr-PKCi (100 μmol/L) did not alter the inhibitory effects of 20-HETE on this channel. In contrast, the tyrosine kinase inhibitor genistein (30 μmol/L) blocked the inhibitory effects of 20-HETE on the large-conductance K+ channel. These data suggest that 20-HETE activates the MAP kinase system in renal arterioles and that the activation of a tyrosine kinase, which is proximal to MEK in this cascade, contributes to the inhibitory effects of 20-HETE on K+-channel activity and its vasoconstrictor effects in the renal arterioles.

AB - The present study examined the hypothesis that activation of protein kinase C (PKC), components of the mitogen-activated protein (MAP) kinase pathway, or both contributes to the inhibitory effects of 20- hydroxyeicosatetraenoic acid (20-HETE) on K+-channel activity and its vasoconstrictor response in renal arterioles. 20-HETE (0.1 to 50 μmol/L) dose-dependently produced a 30% increase in PKC activity and a fivefold rise in the expression of active extracellular signal-regulated kinase 1 (ERK1) and ERK2 proteins in renal microvessels. 20-HETE (0.01 to 1 μmol/L) reduced the diameter of isolated perfused renal interlobular arterioles by 33±2%. Blockade of PKC activity with an N-myristoylated PKC pseudosubstrate inhibitor (Myr-PKCi, 100 μmol/L) or calphostin C (0.5 μmol/L) had no significant effect on the vasoconstrictor response to 20-HETE. In contrast, the tyrosine kinase inhibitors genistein (30 μmol/L) and tyrphostin 25 (10 μmol/L) reduced the response to 20-HETE by 76.5±2.1% and 67.5±1.8%, respectively. A specific inhibitor of mitogen-activated extracellular signal- regulated kinase (MEK), PD98059, had no effect on the vasoconstrictor response to 20-HETE. In cell-attached patches on renal vascular smooth muscle cells, 20-HETE reduced the open state probability of a large-conductance K+ channel (from 0.0026±0.0004 to 0.0006±0.0001). The Myr-PKCi (100 μmol/L) did not alter the inhibitory effects of 20-HETE on this channel. In contrast, the tyrosine kinase inhibitor genistein (30 μmol/L) blocked the inhibitory effects of 20-HETE on the large-conductance K+ channel. These data suggest that 20-HETE activates the MAP kinase system in renal arterioles and that the activation of a tyrosine kinase, which is proximal to MEK in this cascade, contributes to the inhibitory effects of 20-HETE on K+-channel activity and its vasoconstrictor effects in the renal arterioles.

KW - Arachidonic acid

KW - Cytochrome P450

KW - Kinase

KW - Muscle, smooth, vascular

KW - Potassium channels

KW - Renal circulation

UR - http://www.scopus.com/inward/record.url?scp=0032946311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032946311&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 414

EP - 418

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1 II

ER -